Fate and PPARγ and STATs-driven effects of the mitochondrial complex I inhibitor tebufenpyrad in liver cells revealed with multi-omics.

Accession: MTBLS4063
Source / host: MetaboLights — EBI MetaboLights FTP
Disease relevance: MASLD / NAFLD / NASH (category: Metabolomic, subtype: metabolomics/lipidomics)
Modality / assay: metabolomics
Platform: metabolite profiling; mass spectrometry; Liquid Chromatography MS - positive - reverse phase; Liquid Chromatography MS - negative - reverse phase; Liquid Chromatography MS - positive
Organism: unspec
Size (indexed): 73.6 GB (79012251849 bytes)
Downloaded bytes: 2.9 MB (3082573 bytes)
Access / raw: public / OPEN-raw

Download

Files

FileSizeSHA256
MTBLS4063.announcement.json190.7 KB6ba1e33d74de848d…
MTBLS4063.mhd.json2.2 MBe42af9fdab82e584…
a_MTBLS4063_LC-MS_HepaRG_dose_cells_NEG.txt9.0 KBd77c9209e9c932b7…
a_MTBLS4063_LC-MS_HepaRG_dose_cells_POS.txt9.0 KBfed53db5980ebf74…
a_MTBLS4063_LC-MS_HepaRG_dose_medium_NEG.txt11.3 KB9b4ab007ab29c0dc…
a_MTBLS4063_LC-MS_HepaRG_dose_medium_POS.txt11.3 KB646cc2fb5546d580…
a_MTBLS4063_LC-MS_HepaRG_kinetic_cells_NEG.txt18.3 KB751f9d5db1fb3c68…
a_MTBLS4063_LC-MS_HepaRG_kinetic_cells_POS.txt18.3 KB5ffc71865129152a…
a_MTBLS4063_LC-MS_HepaRG_kinetic_medium_NEG.txt17.4 KBad721f79c2c2b4d4…
a_MTBLS4063_LC-MS_HepaRG_kinetic_medium_POS.txt17.4 KB7770de9a68fefdc0…
a_MTBLS4063_LC-MS_Human_PHH_dose_cells_NEG.txt5.5 KB93292ab14e7f76a6…
a_MTBLS4063_LC-MS_Human_PHH_dose_cells_POS.txt6.1 KBd1d2285ec176550b…
a_MTBLS4063_LC-MS_Human_PHH_dose_medium_NEG.txt6.1 KBf5c5a6a65624d534…
a_MTBLS4063_LC-MS_Human_PHH_dose_medium_POS.txt6.1 KBe06143cfade23912…
a_MTBLS4063_LC-MS_Rat_PRH_dose_cells_NEG.txt5.9 KB43f4a29bb02235eb…
a_MTBLS4063_LC-MS_Rat_PRH_dose_cells_POS.txt5.9 KBf10f31baf9924f56…
a_MTBLS4063_LC-MS_Rat_PRH_dose_medium_NEG.txt6.0 KB190ab22dd36314e2…
a_MTBLS4063_LC-MS_Rat_PRH_dose_medium_POS.txt6.0 KB615a90832642aef4…
i_Investigation.txt18.5 KBcf50e5e6dd8fab3a…
m_MTBLS4063_LC-MS_HepaRG_dose_cells_NEG_v2_maf.tsv40.7 KB981efac6b7e02f6f…
m_MTBLS4063_LC-MS_HepaRG_dose_cells_POS_v2_maf.tsv54.6 KB0830716bdda74c21…
m_MTBLS4063_LC-MS_HepaRG_dose_medium_NEG_v2_maf.tsv14.3 KBf92ad01fdfc91968…
m_MTBLS4063_LC-MS_HepaRG_dose_medium_POS_v2_maf.tsv11.3 KB6bf9e57fab4db9fd…
m_MTBLS4063_LC-MS_HepaRG_kinetic_cells_NEG_v2_maf.tsv24.1 KB4e56800c1f97085e…
m_MTBLS4063_LC-MS_HepaRG_kinetic_cells_POS_v2_maf.tsv16.7 KBcda035c7b8e2b854…
m_MTBLS4063_LC-MS_HepaRG_kinetic_medium_NEG_v2_maf.tsv48.6 KB2f6a7720bda909ca…
m_MTBLS4063_LC-MS_HepaRG_kinetic_medium_POS_v2_maf.tsv46.4 KB2fc6cd713c461db8…
m_MTBLS4063_LC-MS_Human_PHH_dose_cells_NEG_v2_maf.tsv3.8 KBd26aed29d9581c64…
m_MTBLS4063_LC-MS_Human_PHH_dose_cells_POS_v2_maf.tsv10.4 KB4adf12c2d1900f1e…
m_MTBLS4063_LC-MS_Human_PHH_dose_medium_NEG_v2_maf.tsv19.4 KBbdd4e179345c6842…
m_MTBLS4063_LC-MS_Human_PHH_dose_medium_POS_v2_maf.tsv26.7 KB19d1c0483dd6dd98…
m_MTBLS4063_LC-MS_Rat_PRH_dose_cells_NEG_v2_maf.tsv2.9 KB090e00402f05da85…
m_MTBLS4063_LC-MS_Rat_PRH_dose_cells_POS_v2_maf.tsv19.0 KB0edd61a088ac8b3b…
m_MTBLS4063_LC-MS_Rat_PRH_dose_medium_NEG_v2_maf.tsv3.1 KB1ddef546f2294f08…
m_MTBLS4063_LC-MS_Rat_PRH_dose_medium_POS_v2_maf.tsv10.9 KBcc4555cbda7ff40f…
s_MTBLS4063.txt53.8 KB82ebcb1222ce561e…

Index note: public study (ISA-Tab+MAF)

Crawled by masld-atlas-crawler v1.0 at 2026-08-02T22:16:08Z.

About this dataset

This metabolite profiling; mass spectrometry; Liquid Chromatography MS - positive - reverse phase; Liquid Chromatography MS - negative - reverse phase; Liquid Chromatography MS - positive dataset provides single-cell gene expression from unspec liver samples, with disease state recorded as MASLD/NAFLD/NASH.

Analyze it in Drylab

Open this dataset in Drylab and ask a question in plain language. The AI agent loads the files, runs the analysis in a ready sandbox and explains each result. A typical first pass:

  1. Load the filtered feature-barcode matrix (HDF5) and run quality control on counts, genes and mitochondrial reads per cell.
  2. Normalize, select variable genes, then cluster the cells and draw a UMAP.
  3. Annotate clusters with marker genes and compare the cell-type mix between conditions.
  4. Run differential expression between cell types or samples to characterize masld/nafld/nash biology.